Surface Chemistry of Biologically Active Reducible Oxide Nanozymes
Overview
Affiliations
Reducible metal oxide nanozymes (rNZs) are a subject of intense recent interest due to their catalytic nature, ease of synthesis, and complex surface character. Such materials contain surface sites which facilitate enzyme-mimetic reactions via substrate coordination and redox cycling. Further, these surface reactive sites are shown to be highly sensitive to stresses within the nanomaterial lattice, the physicochemical environment, and to processing conditions occurring as part of their syntheses. When administered in vivo, a complex protein corona binds to the surface, redefining its biological identity and subsequent interactions within the biological system. Catalytic activities of rNZs each deliver a differing impact on protein corona formation, its composition, and in turn, their recognition, and internalization by host cells. Improving the understanding of the precise principles that dominate rNZ surface-biomolecule adsorption raises the question of whether designer rNZs can be engineered to prevent corona formation, or indeed to produce "custom" protein coronas applied either in vitro, and preadministration, or formed immediately upon their exposure to body fluids. Here, fundamental surface chemistry processes and their implications in rNZ material performance are considered. In particular, material structures which inform component adsorption from the application environment, including substrates for enzyme-mimetic reactions are discussed.
Zamyatina E, Goryacheva O, Popov A, Popova N Antioxidants (Basel). 2025; 13(12.
PMID: 39765774 PMC: 11672564. DOI: 10.3390/antiox13121445.
Said R, Ghazzy A, Shakya A, Hunaiti A Bioanalysis. 2024; 16(23-24):1261-1278.
PMID: 39589819 PMC: 11727870. DOI: 10.1080/17576180.2024.2415779.
Oxygen-Binding Sites of Enriched Gold Nanoclusters for Capturing Mitochondrial Reverse Electrons.
Liao F, Chen S, Yao C, Wu T, Liu M, Hsu C Nano Lett. 2024; 24(36):11202-11209.
PMID: 39207943 PMC: 11403762. DOI: 10.1021/acs.nanolett.4c02331.
Sozarukova M, Kozlova T, Beshkareva T, Popov A, Kolmanovich D, Vinnik D Nanomaterials (Basel). 2024; 14(9).
PMID: 38727363 PMC: 11085435. DOI: 10.3390/nano14090769.
Neuromodulation by nanozymes and ultrasound during Alzheimer's disease management.
Karthika V, Sridharan B, Nam J, Kim D, Lim H J Nanobiotechnology. 2024; 22(1):139.
PMID: 38555420 PMC: 10981335. DOI: 10.1186/s12951-024-02406-7.